Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP371705.RAAb5Pyk9EPmF2Amvyjb1q3yBe0ZBv5QH3JnoY5QumWps130_assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP371705.RAAb5Pyk9EPmF2Amvyjb1q3yBe0ZBv5QH3JnoY5QumWps130_provenance.
• NP172207.RAt6jppihtp2xHZkQDd4iT21-A7Xgpg3ktwCoR7kCaiUw130_assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP172207.RAt6jppihtp2xHZkQDd4iT21-A7Xgpg3ktwCoR7kCaiUw130_provenance.
• NP274137.RAj1mSDIPW-1639OwcW_mcyXQ_AOlmWUPhgFuKgH6AABQ130_assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP274137.RAj1mSDIPW-1639OwcW_mcyXQ_AOlmWUPhgFuKgH6AABQ130_provenance.
• NP599388.RA8YGSaCALM4HXlC_ZtjINYISNgrU_Cdsj3X9zkYEQOrc130_assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP599388.RA8YGSaCALM4HXlC_ZtjINYISNgrU_Cdsj3X9zkYEQOrc130_provenance.
• NP517704.RAyMQF299V7JuRGHYpTzawgKbwArK06gDgLn7yK9EViI4130_assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP517704.RAyMQF299V7JuRGHYpTzawgKbwArK06gDgLn7yK9EViI4130_provenance.
• assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP930475.RA8nUybMrLPullPw5ZvUoAjEHtvrK11DuMLhIfwinAFlE130_assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930475.RA8nUybMrLPullPw5ZvUoAjEHtvrK11DuMLhIfwinAFlE130_provenance.
• NP504813.RAPJKsBxB6qRMIyQe21EJeWL0l3sqtdwI-FVQ2fXKXLS0130_assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504813.RAPJKsBxB6qRMIyQe21EJeWL0l3sqtdwI-FVQ2fXKXLS0130_provenance.
• assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP519901.RAAo2hUFGphij2j3G9b-cuuNURMbXs4hWSaYpMQyR7M9k130_assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519901.RAAo2hUFGphij2j3G9b-cuuNURMbXs4hWSaYpMQyR7M9k130_provenance.
• NP519900.RAfnYJeuYMAELQuVi2mClTcgmpwjLvwdTzfBpfAaSClmQ130_assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519900.RAfnYJeuYMAELQuVi2mClTcgmpwjLvwdTzfBpfAaSClmQ130_provenance.
• NP809663.RAv-789koJ14IdWqopBjNf259y_HTHNzeUpwc6Rr-47w4130_assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP809663.RAv-789koJ14IdWqopBjNf259y_HTHNzeUpwc6Rr-47w4130_provenance.
• NP294575.RApSrv28XKjeNPJdKYB8UcO261Z8yXyJSC3nbxMuWXjao130_assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294575.RApSrv28XKjeNPJdKYB8UcO261Z8yXyJSC3nbxMuWXjao130_provenance.
• NP590068.RAymDCcNOzbsVA76UN9sYjhORrgJdlMMvLiFvgoVX0L88130_assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP590068.RAymDCcNOzbsVA76UN9sYjhORrgJdlMMvLiFvgoVX0L88130_provenance.
• NP809631.RAOSdDA_UPy4vJPyAnhgCuweFsV0vtbQNQJfmcnb2DuLQ130_assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP809631.RAOSdDA_UPy4vJPyAnhgCuweFsV0vtbQNQJfmcnb2DuLQ130_provenance.
• NP519902.RAMrfnXWckvpWX_q7cCWqDsv9nfT0YRg-B1NGuz6KRfSg130_assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519902.RAMrfnXWckvpWX_q7cCWqDsv9nfT0YRg-B1NGuz6KRfSg130_provenance.
• NP900239.RA3HiL8JogYAxm2CFl7-dkyr7l6e_ypGu9sEsTNOPa9u4130_assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900239.RA3HiL8JogYAxm2CFl7-dkyr7l6e_ypGu9sEsTNOPa9u4130_provenance.
• NP900256.RA74C31Vqgure4LM7PmdcsnovRCz9nzA5TgtOf3mu9tiU130_assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900256.RA74C31Vqgure4LM7PmdcsnovRCz9nzA5TgtOf3mu9tiU130_provenance.
• NP519903.RA62VNT9xa12l1AYPFg1BpX8WP0cQxd_8KA83D7zsZzFw130_assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519903.RA62VNT9xa12l1AYPFg1BpX8WP0cQxd_8KA83D7zsZzFw130_provenance.